New combo treatment may sharpen vision in keratoconus patients
NCT ID NCT07372911
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining a laser vision correction (PRK) with corneal cross-linking improves eyesight and corneal shape better than cross-linking alone in people with keratoconus, a condition that thins and bulges the cornea. Fifty adults aged 18-40 with mild to moderate keratoconus will be randomly assigned to one of two groups. The main goal is to see if the combination leads to better corrected vision after one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Excimer laser (PRK) and riboflavin-UVA cross-linking
What this could lead to
If successful, this approach could offer better vision correction and corneal stability for people with keratoconus, potentially reducing the need for glasses or contact lenses.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply to everyone. Risks include corneal haze, infection, or no significant improvement over standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto de Oftalmología FAP Conde de Valenciana, IAP Sede Centro
RECRUITINGMexico City, Mexico City, 06800, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••